RxDoctor Payments Data

Raymond Edison, MD

Internal Medicine · Southfield, MINPI 1679782346

Payments from drug & device makers

$851in general payments, 2019–2025

Across 45 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$185
  • Braeburn Inc.$128
  • Indivior Inc.$108
  • Alkermes, Inc.$104
  • Novartis$67
  • Avanir Pharmaceuticals, Inc.$62
  • plus $198 from 8 others

What the payments were for

  • Food & beverage$77992%
  • Education$728%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$851 in reported general payments places this provider in the 70th percentile of 4,567 internal medicine providers in Michigan.

See all internal medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$25,672
Medicare patients
32
Services billed
207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VivitrolNaltrexone Microspheres14$22,731
OzempicSemaglutide13$12,385
EliquisApixaban18$10,193
XareltoRivaroxaban13$6,774
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$5,663
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$3,490
Levemir FlexpenInsulin Detemir14$2,251
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl11$1,727
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,400
Albuterol Sulfate HfaAlbuterol Sulfate41$1,369
Methocarbamol35$665
Nifedipine ErNifedipine48$662
Clindamycin Phosphate15$645
Nano 2nd Gen Pen NeedlePen Needle, Diabetic11$577
Amlodipine Besylate103$560

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Vivitrol$104$22,73114 claims
Novo NordiskOzempic$20$12,38513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,567 internal medicine providers in Michigan.

Other internal medicine in Southfield

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →